Clearance of hepatitis B virus (HBV) DNA from the blood seldom occurs without treatment even after a decade, researchers reported at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010) last month in Vienna. Among people who experience hepatitis B "e" antigen (HBeAg) clearance, however, the likelihood of also achieving undetectable viral load was higher, approaching 50% at 10 years.
C-J. Chen from National Taiwan University and colleagues assessed the likelihood and factors associated with spontaneous clearance of HBV viral load in a sub-study of the large REVEAL-HBV trial, which looked at long-term outcomes including liver cancer among people with chronic hepatitis B.
The sub-study included 1289 participants with high HBV DNA levels (> 10,000 copies/mL) but no evidence of cirrhosis at study entry.
Results
"Spontaneous seroclearance of HBV DNA was a rare event, even after HBeAg seroclearance," the investigators concluded. "Lower baseline viral load and central obesity [were] associated with higher possibility of decreasing HBV DNA to undetectable level, whereas higher serum ALT level during follow-up associated with a lower possibility of HBV DNA decline."
Genomics Research Center, Academia Sinica, National Taiwan University, Taipei, Taiwan ROC; Research and Development, Bristol-Myers Squibb Company, Willingford, CT.
5/14/10
Reference
C-J Chen, H-I Yang, C-L Jen, and others. Incidence and determinants of spontaneous decline of HBV DNA to undetectable level in patients with high viral load. 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010). Vienna, Austria. April 14-18, 2010. (Abstract).